Obinutuzumab
Products in Health Canada’s databases that list Obinutuzumab as a medicinal or active ingredient, under this spelling. The same substance can be listed under another name (a salt, a common name), which has its own page.
- Drug products
- 1
- 1 authorized now
- Natural health products
- 0
- 0 active licences
- Notices of Compliance
- 14
- Products in all
- 1
Drug products
Authorized products first.
| Name | DIN | Status | Holder | Status since |
|---|---|---|---|---|
| GAZYVA (25 MG) | 02434806 | Marketed | Hoffmann-La Roche Limited |
Notices of Compliance
Approvals of drug submissions that list it, newest first.
- GAZYVAJanuary 22, 2026 · NOC 36775
- GAZYVAJune 6, 2024 · NOC 33397
- GAZYVAFebruary 1, 2023 · NOC 30021
- GAZYVAJuly 25, 2022 · NOC 28643
- GAZYVAMay 11, 2022 · NOC 28131
- GAZYVAFebruary 8, 2020 · NOC 25170
- GAZYVANovember 23, 2018 · NOC 21546
- GAZYVAAugust 16, 2018 · NOC 21222
- GAZYVAJuly 5, 2018 · NOC 21054
- GAZYVASeptember 15, 2017 · NOC 19798
- GAZYVAJanuary 13, 2017 · NOC 18862
- GAZYVADecember 29, 2016 · NOC 18812
- GAZYVANovember 10, 2015 · NOC 17464
- GAZYVANovember 25, 2014 · NOC 16352